Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab

With durable cancer responses, genetically modified cell therapies are being implemented in various cancers. However, these immune effector cell therapies can cause toxicities, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Pseudogout ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang T., Tayar, Jean, Fu, Siqing, Ke, Danxia, Norry, Elliot, Sun, Amy, Miller, Juli, Hong, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264871/
https://www.ncbi.nlm.nih.gov/pubmed/34233963
http://dx.doi.org/10.1136/jitc-2021-002716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264871/
https://www.ncbi.nlm.nih.gov/pubmed/34233963
http://dx.doi.org/10.1136/jitc-2021-002716

Ejemplares similares